Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants
  2. Zhang, Ling; Norberg, Scott M; Karimipour, Farrah; Davies, John S; Kuznetsov, Alex; Lassoued, Wiem; Burnett, Daniel; Homan,Philip; Cam, Margaret; Sinkoe, Andrew; Xue, Ping; Gulley, James L; Hinrichs, Christian S
  3. Journal for Immunotherapy of Cancer. 2024, Nov 18; 12(11):
  1. 2.   Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
  2. Yossef, Rami; Krishna, Sri; Sindiri, Sivasish; Lowery, Frank J; Copeland, Amy R; Gartner, Jared J; Parkhurst, Maria R; Parikh, Neilesh B; Hitscherich, Kyle J; Levi, Shoshana T; Chatani, Praveen D; Zacharakis, Nikolaos; Levin, Noam; Vale, Nolan R; Nah, Shirley K; Dinerman, Aaron; Hill, Victoria K; Ray, Satyajit; Bera, Alakesh; Levy, Lior; Jia, Li; Kelly,Michael; Goff, Stephanie L; Robbins, Paul F; Rosenberg, Steven A
  3. Cancer Cell. 2023, Dec 11; 41
  1. 3.   Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
  2. Ade, Catherine M; Sporn, Matthew J; Das,Sudipto; Yu, Zhiya; Hanada, Ken-Ichi; Qi, Yue A; Maity, Tapan; Zhang, Xu; Guha, Udayan; Andresson,Thorkell; Yang, James C
  3. Journal for Immunotherapy of Cancer. 2023, Sep; 11(9):
  1. 4.   A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers
  2. Hanada, Ken-Ichi; Zhao, Chihao; Gil-Hoyos, Raul; Gartner, Jared J; Chow-Parmer, Christopher; Lowery, Frank J; Krishna, Sri; Prickett, Todd D; Kivitz, Scott; Parkhurst, Maria R; Wong,Nathan; Rae, Zachary; Kelly, Michael C; Goff, Stephanie L; Robbins, Paul F; Rosenberg, Steven A; Yang, James C
  3. Cancer Cell. 2022, Apr 13;
  1. 5.   Immuno-transcriptomic profiling of extracranial pediatric solid malignancies
  2. Brohl, Andrew S; Sindiri, Sivasish; Wei, Jun S; Milewski, David; Chou, Hsien-Chao; Song, Young K; Wen, Xinyu; Kumar, Jeetendra; Reardon, Hue V; Mudunuri,Uma; Collins,Jack; Nagaraj, Sushma; Gangalapudi, Vineela; Tyagi, Manoj; Zhu, Yuelin J; Masih, Katherine E; Yohe, Marielle E; Shern, Jack F; Qi, Yue; Guha, Udayan; Catchpoole, Daniel; Orentas, Rimas J; Kuznetsov, Igor B; Llosa, Nicolas J; Ligon, John A; Turpin, Brian K; Leino, Daniel G; Iwata, Shintaro; Andrulis, Irene L; Wunder, Jay S; Toledo, Silvia R C; Meltzer, Paul S; Lau, Ching; Teicher, Beverly A; Magnan, Heather; Ladanyi, Marc; Khan, Javed
  3. Cell reports. 2021, Nov 23; 37(8): 110047.
  1. 6.   Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins
  2. Tewary,Poonam; Brooks, Alan D.; Xu, Ya-Ming; Wijeratne, E. M. Kithsiri; Babyak, Ashley L.; Back, Timothy C.; Chari,Raj; Evans,Christine; Henrich,Curtis; Meyer,Thomas; Edmondson,Elijah; de Aquino, Maria T. Prudente; Kanagasabai, Thanigaivelan; Shanker, Anil; Gunatilaka, A. A. Leslie; Sayers, Thomas J.
  3. Cancer Research. 2021, Jun 15; 81(12): 3374-3386.
  1. 7.   Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
  2. Pedreno-Lopez, Nuria; Rosen, Brandon C.; Flores, Walter J.; Gorman, Matthew J.; Voigt, Thomas B.; Ricciardi, Michael J.; Crosno, Kristin; Weisgrau, Kim L.; Parks, Christopher L.; Lifson,Jeffrey; Alter, Galit; Rakasz, Eva G.; Magnani, Diogo M.; Martins, Mauricio A.; Watkins, David I.
  3. Frontiers In Immunology. 2021, Mar 16; 12
  1. 8.   Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
  2. Mo, George; Wang, Hao-Wei; Talleur, Aimee C; Shahani, Shilpa A; Yates, Bonnie; Shalabi, Haneen; Douvas, Michael G; Calvo, Katherine R; Shern, Jack F; Chaganti, Sridhar; Patrick, Katharine; Song, Young; Fry, Terry J; Wu,Xiaolin; Triplett, Brandon M; Khan, Javed; Gardner, Rebecca A; Shah, Nirali N
  3. Journal for immunotherapy of cancer. 2020, Nov; 8(2): pii: e001563.
  1. 9.   Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
  2. Brudno, Jennifer N; Lam, Norris; Vanasse, Danielle; Shen, Yueh-Wei; Rose, Jeremy J; Rossi, John; Xue, Allen; Bot, Adrian; Scholler, Nathalie; Mikkilineni, Lekha; Roschewski, Mark; Dean, Robert; Cachau,Raul; Youkharibache, Philippe; Patel, Rashmika; Hansen, Brenna; Stroncek, David F; Rosenberg, Steven A; Gress, Ronald E; Kochenderfer, James N
  3. Nature medicine. 2020, Jan 20;
  1. 10.   Preferential Small Intestine Homing and Persistence of CD8 T Cells in Rhesus Macaques Achieved by Molecularly-Engineered Expression of CCR9 and Reduced Ex Vivo Manipulation
  2. Trivett,Matthew; Burke, James D; Deleage,Claire; Coren,Lori; Hill,Brenna; Jain, Sumiti; Barsov, Eugene V; Breed,Matthew; Kramer,Josh; Del Prete,Greg; Lifson,Jeffrey; Swanstrom,Adrienne; Ott, David E
  3. Journal of virology. 2019, NOV; 93(21): pii: JVI.00896-19.
  1. 11.   Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection
  2. Sektioglu, I. M.; Carretero, R.; Bender, N.; Bogdan, C.; Garbi, N.; Umansky, V.; Umansky, L.; Urban, K.; von Knebel-Doberitz, M.; Somasundaram, V.; Wink, D.; Beckhove, P.; Hammerling, G. J.
  3. Oncoimmunology. 2016 5(10): e1204506.
  1. 12.   Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
  2. Muranski, P.; Borman, Z. A.; Kerkar, S. P.; Klebanoff, C. A.; Ji, Y.; Sanchez-Perez, L.; Sukumar, M.; Reger, R. N.; Yu, Z. Y.; Kern, S. J.; Roychoudhuri, R.; Ferreyra, G. A.; Shen, W.; Durum, S. K.; Feigenbaum, L.; Palmer, D. C.; Antony, P. A.; Chan, C. C.; Laurence, A.; Danner, R. L.; Gattinoni, L.; Restifol, N. P.
  3. Immunity. 2011, Dec; 35(6): 972-985.
  1. 13.   Immunotherapy reaches new milestones in cancer eradication
  2. Kotlan, B.; Umansky, V.; Malyguine, A. M.; Marincola, F. M.; Shurin, M. R.
  3. Immunotherapy. 2011, Oct; 3(10): 1131-1137.
  1. 14.   Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication
  2. Barsov, E. V.; Trivett, M. T.; Minang, J. T.; Sun, H. S.; Ohlen, C.; Ott, D. E.
  3. Plos One. 2011, Aug; 6(8): 9.
  1. 15.   Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy
  2. Barsov, E. V.
  3. Immunotherapy. 2011, Mar; 3(3): 407-421.
  1. 16.   Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells
  2. Shafer-Weaver, K. A.; Watkins, S. K.; Anderson, M. J.; Draper, L. J.; Malyguine, A.; Alvord, W. G.; Greenberg, N. M.; Hurwitz, A. A.
  3. Cancer Research. 2009 69(15): 6256-6264.
  1. 17.   Melanoma Progression Despite Infiltration by In Vivo-primed TRP-2-specific T Cells
  2. Singh, V.; Ji, Q. Y.; Feigenbaum, L.; Leighty, R. M.; Hurwitz, A. A.
  3. Journal of Immunotherapy. 2009 32(2): 129-139.
  1. 18.   Novel Human Interleukin-15 Agonists
  2. Zhu, X. Y.; Marcus, W. D.; Xu, W. X.; Lee, H. I.; Han, K. P.; Egan, J. O.; Yovandich, J. L.; Rhode, P. R.; Wong, H. C.
  3. Journal of Immunology. 2009 183(6): 3598-3607.
  1. 19.   Sensitizing tumor cells to immune-mediated cytotoxicity
  2. Shanker, A.; Sayers, T.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 163-171.
  1. 20.   Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model
  2. He, H.; Wisner, P.; Yang, G. J.; Hu, H. M.; Haley, D.; Miller, W.; O'Hara, A.; Alvord, W. G.; Clegg, C. H.; Fox, B. A.; Urba, W. J.; Walker, E. B.
  3. Journal of Translational Medicine. 2006, Jun; 4
  1. 21.   Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes
  2. Baskar, S.; Kobrin, C. B.; Kwak, L. W.
  3. Journal of Clinical Investigation. 2004 113(10): 1498-1510.
  1. 22.   Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
  2. Overwijk, W. W.; Theoret, M. R.; Finkelstein, S. E.; Surman, D. R.; de Jong, L. A.; Vyth-Dreese, F. A.; Dellemijn, T. A.; Antony, P. A.; Spiess, P. J.; Palmer, D. C.; Heimann, D. M.; Klebanoff, C. A.; Yu, Z. Y.; Hwang, L. N.; Feigenbaum, L.; Kruisbeek, A. M.; Rosenberg, S. A.; Restifo, N. P.
  3. Journal of Experimental Medicine. 2003 198(4): 569-580.
  1. 23.   Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta(2)- microglobulin gene-modified autologous tumor cells
  2. Meijer, S. L.; Dols, A.; Urba, W. J.; Hu, H. M.; Smith, J. W.; Vetto, J.; Wood, W.; Doran, T.; Chu, Y.; Sayaharuban, P.; Alvord, W. G.; Fox, B. A.
  3. Journal of Immunotherapy. 2002 25(4): 359-372.
  1. 24.   Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
  2. Kershaw, M. H.; Wang, G.; Westwood, J. A.; Pachynski, R. K.; Tiffany, H. L.; Marincola, F. M.; Wang, E.; Young, H. A.; Murphy, P. M.; Hwu, P.
  3. Human Gene Therapy. 2002 13(16): 1971-1980.
  1. 25.   Engineering of macrophages to produce IFN-gamma in response to hypoxia
  2. Carta, L.; Pastorino, S.; Melillo, G.; Bosco, M. C.; Massazza, S.; Varesio, L.
  3. Journal of Immunology. 2001 166(9): 5374-5380.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel